Firstep Synthetic cannabis (K2) Drug Screen Test - Taiwan Registration 75ea998c3b06a9cfa76e2a035021a4dc
Access comprehensive regulatory information for Firstep Synthetic cannabis (K2) Drug Screen Test in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 75ea998c3b06a9cfa76e2a035021a4dc and manufactured by FIRSTEP BIORESEARCH INC.. The authorized representative in Taiwan is FIRSTEP BIORESEARCH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
75ea998c3b06a9cfa76e2a035021a4dc
Ministry of Health Medical Device Manufacturing No. 005368
Product Details
Synthetic cannabis, K2, JWH-073 metabolites in urine were detected by immunoqualitative analysis, and the results were interpreted by naked eye to preliminarily screen for drug abuse of synthetic marijuana. This product can be used by professionals and the general public. The detection thresholds of this product are JWH-018 50 ng/mL and JWH-073 25 ng/mL. This product is used as a preliminary screening for the abuse of synthetic cannabis drugs, if drug abuse is suspected, a gas chromatography mass spectrometry (GC/MS) test is required for confirmatory test.
A Clinical chemistry and clinical toxicology
A3870 Cannabinoid Test System
Produced in Taiwan, China
Dates and Status
Jan 18, 2017
Jan 18, 2027